Fluidigm Introduces Single-Cell TCR Sequencing on the C1 System at Immunology 2016™
SOUTH SAN FRANCISCO, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of Single-Cell TCR Sequencing, a new immunology application on the C1™ system that enables in-depth profiling of T cells at …